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Summary 
B  cell knockout mice p,  MT/p,  MT were used to examine the requirement for B  cell antigen 
(Ag)  presentation in the  establishment of CD4 +  T  cell tolerance.  CD4 + T  cells  from p,  MT 
mice injected with exogenous protein Ag in adjuvant responded to in vitro challenge by tran- 
scription of cytokine mKNA, cytokine secretion, and proliferation. Peripheral tolerance could 
be established in  p~MT  mice with a single  dose of deaggragated protein.  This tolerance was 
manifested by a loss of T  cell proliferation and cytokine production  (including both T  helper 
cell type 1 [Thl]- and Th2-related cytokines), indicating that B  cells are not required for the 
induction  of peripheral T  cell tolerance and suggesting that the dual zone tolerance theory is 
not applicable to all protein Ags and is not mediated through Ag presentation by B cells. 
T 
he  role  of B  cells  in  Ag  presentation  to  peripheral 
CD4 +  T  cell responses  is  controversial.  Although  B 
cells are the most abundant MHC class II-positive cell and 
have been shown in some studies to be involved in the ac- 
tivation of peripheral T  cells,  other investigators have ar- 
gued against the notion that B  cells  are necessary as APCs 
for induction of T  cell responses. Thus, results from studies 
have ranged from, first, the B  cell as the  crucial initiating 
APC in the lymph node (1), through second, the B cell as a 
necessary mediator of T  cell clonal expansion and second- 
ary proliferation (2-5), to third, normal priming and prolif- 
eration  of T  cells  in  the  absence  of B  cells  (6,  7).  These 
studies  all  examined Ag-specific T  cell activation in mice 
that had been rendered deficient in B  cells,  either by con- 
tinuous injection of anti-p, Ab, by reconstitution  of SCID 
mice with naive T  cells,  or, most recently, by targeted de- 
letion  of either  the  IgM heavy chain  gene  (8)  or  the JH 
gene segment (5, 9). The role of B cells in the induction of 
peripheral T  cell tolerance is less controversial. B  cells  can 
serve as APCs in the induction  of Ag-specific tolerance in 
naive CD4 + and CD8 + T  cells  (10,  11)  and in Ag-specific 
T  cell clones  (12).  These reports led to speculation by in- 
vestigators that tolerance induction in virgin T  cells is a pri- 
mary function of the B cell. 
To reevaluate the role of B  cells  as APCs for activation 
and tolerization ofCD4 + T  cells, we used the B cell knock- 
out mouse ~MT/p~MT (hereafter p~MT), which was gen- 
erated  by  introduction  of a  nonsense  mutation  into  the 
transmembrane exon of the IgM heavy chain gene, result- 
ing in a total deletion of  B cells (13).  The Ag used to inves- 
tigate  CD4 +  T  cell  responses  in  these  mice  was  human 
~/-globulin (HGG),  1 which is a T-dependent Ag able to in- 
duce either tolerance or activation ofT cells, depending on 
the injection procedure.  HGG injected subcutaneously in 
adjuvant induces T  cell proliferation and cytokine secretion 
as well as a significant anti-HGG Ag response, whereas a 
single injection of deaggregated HGG (DHGG) induces a 
long-lasting  peripheral  tolerance  that  affects both B  cells 
and T  cells (reviewed in 14 and 15).  In the case ofT cells, 
this tolerance results in a loss  of proliferation and produc- 
tion of cytokines (both Thl- and Th2-related [16,  17]). 
In this report, we show that CD4 + T  cells from HGG- 
primed  [zMT mice can be activated to  proliferate and to 
secrete both Thl- and Th2-related cytokines in response to 
HGG challenge in vitro. When  ~zMT mice were injected 
with  tolerogenic  DHGG, peripheral  tolerance  was  estab- 
fished at a level similar to that seen in the normal controls, 
as evidenced by decreased proliferation and cytokine secre- 
tion in  response to HGG in vitro.  Taken together,  these 
data  indicate  that B  cells  are  not necessary participants  as 
APCs for the  induction  of peripheral T  cell activation or 
tolerance. 
Materials  and Methods 
Mice.  p~MT/p~MT  breeder stocks  were  originally  obtained 
from The Jackson Laboratory (Bar Harbor, ME) and were housed 
1Abbreviations used in  this paper: AHGG, aggregated human y-globulin; 
DC, dendritic cell; DHGG, deaggregated  human "/-globulin; HGG, hu- 
man "/-globulin; IF, immunofluorescence; PPD, purified protein deriva- 
tive; SN, supematant. 
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search  Institute  (La Jolla,  CA).  C57BL/6  mice  were  obtained 
from  the  Scripps  Research  Institute breeding colony and were 
housed and treated identically. 
Antigens.  HGG was purified from Cohn fraction II of human 
plasma  (Hyland Laboratories,  Glendale,  CA)  as  described  (18), 
purified protein derivative (PPD) was obtained from the Statens 
Seruminstitut (Copenhagen, Denmark),  and KLH was  obtained 
from Calbiochem Novabiochem (LaJolla, CA). 
Immunization  and Tolerance Induction.  DHGG was prepared by 
ultracentrifugation of HGG as described (16).  Mice were  toler- 
ized by a single injection of 1 mg DHGG i.p. in 1 ml saline. 7-10 
d after tolerization, mice were injected with 200 Ixg HGG s.c. in 
CFA (Sigma Chemical Co., St.  Louis, MO). Draining LNs were 
used 8-12 d after injection. 
Cell Preparations and Culture.  Draining  LNs  were  removed 
8-12 d after injection, and CD4 + T  cells were obtained by nega- 
tive selection with an mAb cocktail and anti-Ig-conjugated mag- 
netic beads (PerSeptive Diagnostics, Cambridge, MA) as described 
(16).  CD4 ++ T  cells were >95% pure after this procedure. APCs 
were generated by depleting splenocytes of T  cells  by treatment 
with anti-Thy 1.2  (Du Pont-New England Nuclear, Wilming- 
ton, DE) plus guinea pig complement (Cedar Lane Laboratories 
Ltd., Hornby, Ontario, Canada). For all assays, T  cells were cul- 
tured at 106/rnl with 1.5 X  106/ml irradiated (3,000 R) APCs in 
the presence of either HGG (1 mg/ml), PPD (25 txg/rnl, Statens 
Seruminstitut), or no Ag as described (16).  To generate culture 
supernatants  (SNs)  and  RNA,  cells  were  cultured  in  24-well 
plates for 48-60  h  with  1 mg/ml HGG,  and SN was  removed 
and 1KNA was isolated from the cells as described (19).  For prolif- 
eration  assays,  quadruplicate  cultures  in  96-well  plates  were 
pulsed with  1 btCi/well [3H]TdR  (Amersham Corp., Arlington 
Heights, IL) for the last 18 h  of culture and then were harvested 
onto glass filters.  Tritium incorporation was measured by liquid 
scintillation spectroscopy. 
Cytokine Analysis.  The R.Nase protection assay for detection 
and quantitation of IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IFN-% 
TNF-ot, and TNFq3 mRNA was performed exactly as previously 
described  (20).  Message  levels were  quantitated by a  series  400 
Phospholmager and ImageQuant Software (Molecular Dynamics, 
Sunnyvale, CA).  Cytokine levels in culture SNs were  measured 
by a two-site sandwich ELISA exactly as previously described (20, 
21).  Cytokine levels from  unstimulated cultures were  routinely 
below the level of detection. 
hnmunofluorescence Staining.  PE-labeled anti-CD4 and fluores- 
cein-labeled anti-CD44  (IM7.8.1),  anti-CD45R_B  (C363.16A), 
and  anti-CD62-L  (MEL-14)  were  obtained from  PharMingen 
(La Jolla, CA). Methods for two-color immunofluorescence (IF) 
staining have been described (22).  Stained cells were analyzed by 
FACScan  |  (Becton Dickinson & Co., San Jose, CA). 
Results 
Initial analyses of the peripheral lymphoid organs of the 
p~MT mice confirmed that there were no detectable surface 
Ig+B220 +  dual-expressing cells in the  spleen or LN  (data 
not shown).  We also examined the phenotype  of the resi- 
dent T  cells by analyzing surface markers that are differen- 
tially expressed by naive and memory CD4 + T  cells. Splenic 
CD4 + cells were stained for cell surface expression of CD44, 
CD45RB,  or CD62L.  CD44 increases and both CD45RB 
and  CD62L  decrease  in  expression  during the  shift  from 
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Figure  1.  Naive and memory 
CD4 +  T  cells  in  normal  and 
btMT mice.  Pooled  spleen cells 
from  2-too-old  ~MT  and 
C57BL/6  (+/+)  mice  were 
stained  with  PE-labeled  anti- 
CD4 and FITC-labeled antibod- 
ies  against  either  CD44, 
CD45RB,  or  CD62L.  PE  + 
events  are  displayed as  fluores- 
cent  histograms, with  markers 
placed to define "high"  cell sur- 
face expression for each marker. 
The percentage  of high  cells is 
shown in each histogram. 
naive to memory status (23-25). The majority of the CD4 + 
spleen cells from 3-mo-old DMT  mice were  found in the 
CD441~  CD45RB hi, and CD62L hi populations (Fig.  1), the 
expected  phenotypes of naive CD4 +  cells  (21).  The naive 
cells were present at levels similar to those seen in the age- 
matched  control  mice.  The  percentage  of CD4 +  T  cells 
that  exhibited  an  activated/memory  phenotype  (CD44  hi, 
CD45RB l~  and  CD62L  l~  was  also  similar  between  the 
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Figure  2.  HGG-specific  proliferation by I*MT and normal CD4 + T 
cells. }*MT T cells were able to proliferate and secrete cytokines in re- 
sponse to HGG and PPD.  Since naive CD4  + T  cells secrete primarily 
IL-2 after initial stimulation (20), the appearance of IL-3, IL-4, 1L-5, and 
IFN-'y in Ag-stimulated cultures from the p,  MT mice was an indication 
that  the T  cells had been primed  in vivo. T  cells were  harvested from 
draining LNs of mice injected  10 d earlier with HGG-CFA; they were 
then cultured with HGG and T depleted, irradiated splenic APCs. Cul- 
tures were harvested at the times shown after being pulsed with I btCi of 
[3H]TdR. 
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Table  2.  Proliferative  Response from Tolerized or Primed LN 
CD4 + T  Cells from Individual p,  MT and Normal Mice 
T cells  Ag  IL-2  IL-3  IL-4  IL-5  IFN-3, 
b~MT  HGG  592  760  <5  12  3,085 
+/+  HGG  301  350  <5  28  1,480 
b~MT  PPD  266  285  <5  <5  4,088 
+/+  PPD  200  163  <5  8  1,800 
CD4 + T cells from draining LNs of mice injected with HGG in CFA 
were cultured for 48 h with irradiated APCs and the indicated Ag. Cul- 
ture supernatants were collected at 48 h. T cells cultured without Ag 
did not secrete detectable levels of cytokine. All cytokine levels are dis- 
played in picograms per milliliter. 
normal and the }*MT mice. The presence of an activated/ 
memory T  cell population suggests that T  cell priming to 
environmental  Ag has occurred in both the normal and the 
knockout mice, despite the absence of B  cell APC activity 
in the }xMT. 
Epstein et al.  (8)  have recently shown that b~MT CD4 + 
T  cells  proliferate  normally after  in vivo  priming and in 
vitro  challenge  with  KLH.  We  have  found  that  laMT 
CD4 + cells can proliferate in response to priming and sub- 
sequent  challenge with  HGG  and  PPD,  as  well  as  with 
KLH  (data not shown). Both the kinetics and the  magni- 
tude of the b~MT proliferative response to HGG were sim- 
ilar to those of the C57BL/6BL response (Fig. 2). Cytokine 
secretion by the  }*MT  CD4 +  T  cells in response to both 
HGG  and PPD  was  also  similar to  that  of the  C57BL/6 
controls (Table  1).  The  cytokine responses were  Ag spe- 
cific, since cells cultured without Ag contained no detect- 
able cytokines (not shown). A multiprobe RNase protection 
assay  was  used to  examine cytokine mlKNA transcription 
in  Ag-stimulated T  cell  cultures.  After  60  h  of culture, 
mRNA for a variety of T  cell-related cytokines, including 
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Figure 3.  Expression  of cytokine mlKNA by Ag-stimulated  CD4 + T 
cells from normal and }*MT mice. CD4  + cells were purified from drain- 
ing LNs 10 d after injection with HGG in CFA and then cultured in the 
presence of APCs and HGG (1 mg/ml). After 60 h, IKNA  was harvested 
from all cells. IKNA  originating  from equal numbers of input cells (at time 
0) was analyzed  with the 1KNase protection assay. Absorbance  units values 
were obtained with a Series 400 Phospholmager. Cytokine message from 
cultures that were not given recall Ag (data not shown) was undetectable. 
[3H]TdR incorporation 
A cpm +  SD 
T ceils  DHGG  HGG  PPD 
IxMT/laMT  -  14,123  +- 1,214  27,180  +  1,374 
p.MT/p~MT  -  21,965  _+ 1,476  33,191  -+ 1,889 
+/+  -  12,447  _+ 738  32,002  +  1,560 
+/+  -  19,755 _+ 694  35,408  +  2,206 
+/+  -  20,823  -+ 1,008  32,382  +  1,458 
b~MT/b~MT  +  1,957 +  292  22,892  +  661 
~MT/p.MT  +  3,792  +  832  32,440  +  2,557 
+/+  +  3,476  +  1,229  38,550  -+ 1,396 
+/+  +  3,939  +  812  30,912  +  2,316 
+/+  +  4,992  +  1,699  31,145  +  1,488 
Mice were tolerized by intraperitoneal injection of DHGG (i mg per 
mouse). 7 d later, all animals  were primed with HGG-CFA. Draining 
LNs were removed 12 d after priming, and purified CD4 + T cells  were 
cultured with APCs and Ag for 96 h. [3H]TdR was added for the last 
16 h of the culture. 
IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IFN-% TNF-ot, and 
TNF-[3, was present (Fig. 3). The cytokine response of both 
normal and I~MT T  cells to Ag-specific stimulation at the 
level of message and protein secretion in both groups was 
diverse and included Thl-related (IL-2, IFN-y) and Th2- 
related (IL-4, IL-5, IL-13) cytokines. 
The induction of peripheral tolerance in ~xMT mice was 
examined by injection of DHGG and subsequent challenge 
with  HGG--CFA. The  experiment in Table 2  shows  the 
response of individual animals to tolerance induction. Ani- 
mals  tolerized  with  DHGG  and  then  challenged  with 
HGG  in  CFA were  unable to  mount a  proliferative re- 
sponse to HGG in vivo. The loss of proliferation to HGG 
was clearly Ag specific, since the proliferation to PPD was 
unaltered. The level of tolerance as measured by decreased 
proliferation appeared similar in both the  normal and the 
txMT mice. There were no detectable cytokines in the cul- 
ture  SN  from the  tolerized mice  (Table 3),  and cytokine 
mlKNA from tolerized T  cells was  not apparent with the 
RNase  protection assay  (data  not shown),  indicating that 
functional aspects of the CD4 +  ceils were also affected by 
the tolerizing regimen. Taken together, these experiments 
show that peripheral CD4 + T  cell tolerance can be induced 
in b~MT mice, indicating that APCs other than B cells have 
the ability to present Ag to CD4 + T  cells in a tolerogenic 
fashion. 
Discussion 
In vivo tolerance to HGG is readily induced in CD4 § T 
cells of IxMT mice as well as normal or near normal CD4 + 
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Tolerized I~MT or Normal Mice 
Tcells  DHGG  AHGG  IL-2  IL-3  IL-4  IL-5  IFN-y 
p,MT  -  +  337  760 
btMT  +  +  <20  <10 
+/+  -  +  101  1,004 
+/+  +  +  <20  <10 
express  appropriate  T  cell costimulatory signals,  any inter- 
action with an Ag-specific virgin T  cell would be  tolero- 
genic.  At an increased Ag concentration,  uptake by other 
MHC  class  II-positive cells  would occur.  These  cells,  the 
so-called professional APCs, would present Ag to the  vir- 
29  358  14,471  gin T  cells  in an immunogenic fashion.  At high Ag con- 
<20  <10  <100  centrations,  all  B  cells  would  take  up  Ag by pinocytosis. 
53  293  58,903  Since  B  cells  far outnumber  other MHC  class  II-positive 
<20  <10  <100  cell types, the result would again be tolerance of the virgin 
T  ceils  (10,  11,  26).  This  explanation  presumes  that  first, 
only B  ceils are able to induce T  cell tolerance; second, B 
cells  are  tolerogenic  even in the  presence  of their specific 
Ag; and third, all non-B cell APCs are constitutive activa- 
tors  of virgin T  cells.  These assumptions provide a frame- 
work  explaining  the  midrange,  immunogenic  dose  of Ag 
and imply that a B  cell-deficient animal would not be able 
to  induce  peripheral  T  cell  tolerance  to  exogenous  Ag. 
However,  the  fact  that  IxMT  T  cells  from  mice  given 
DHGG  are  tolerized  rather  than  activated  indicates  that 
dual zone tolerance cannot be explained by the above hy- 
pothesis.  In further support  of the  suggestion that periph- 
eral T  cell  tolerance  is not solely dependent  on B  cell Ag 
presentation  is the work of Vella  et al.  (27),  showing that 
tolerance to soluble peptide and to superantigen can be in- 
duced in B  cell knockout mice.  Actually, there is no evi- 
dence  for  two  zones  of tolerance  to  HGG  over  a  wide 
range  of tolerogenic  doses  (10 mg per mouse  to 5  pg per 
mouse)  (28). The experimental  evidence for dual zone tol- 
erance in an immunocompetent,  adult animal is limited to 
one Ag: BSA (29),  and both Dresser  (30)  and Thorbecke 
and Benacerraf (31)  have speculated  that  the  intermediate 
priming dose of BSA was actually due to low level contam- 
ination of the protein preparation by immunogenic aggre- 
gates. Since there is no experimental  evidence that this in- 
termediate  priming  zone  exists  for  most  Ags,  and  our 
results,  along with  those  of Vella  et  al.  (27),  clearly show 
that  resting  B  cells  are  not  the  only tolerogenic  APC  in 
vivo,  the  tolerogenic  capacity  of non-B  cell  APCs  (e.g., 
macrophages  and  DCs)  needs  to  be  examined.  In  fact, 
Finkelman  et al.  have recently shown that Ags targeted  to 
DCs can induce T  cell tolerance in vivo (Finkelman,  F.D., 
A.  Lees,  R.  Birnbaum,  W.C.  Gause,  and  S.C.  Morris, 
manuscript submitted for publication).  It may well be that 
under the appropriate conditions, every APC is able to in- 
duce  either  a  tolerogenic  or an  immunogenic  T  cell  re- 
sponse.  There is abundant evidence that peripheral  T  cells 
are tolerized in response to Ags presented by nontraditional 
APCs in the absence of appropriate costimulation (32-34). 
In  the  HGG  system,  the  immunological  response  de- 
pends  primarily  on  the  form  of  the  Ag  injected;  i.e., 
DHGG  induces  tolerance,  whereas  aggregated  HGG  in- 
duces activation and T  cell proliferation.  It has been dem- 
onstrated that aggregated HGG is aggressively processed by 
the APCs,  resulting in the  secretion  of cytokines (35-37). 
On the other hand, DHGG is not processed by APCs in a 
manner that results in the release  of cytokines. The activa- 
tion state of the initial APC plays a critical role in the sub- 
sequent T  cell response, since the injection  of either IL-1, 
CD4 + T Cell Activation and Tolerance  Induction in B Cell Knockout Mice 
CD4 + T cells from tolerized (DHGG) or primed (AHGG) mice were 
cultured in the presence of HGG and APCs. Culture supematants were 
colJected after 48 h and examined for the presence of the cytokines 
shown by sandwich ELISA as in Table 1. T cells cultured without Ag 
did not secrete detectable levels of cytokine. All cytokine levels are dis- 
played in picograms  per milliliter. AHGG, aggregated  human -/-globulin. 
T  cell responses to several T-dependent Ags. The fact that 
endogenous T  cell  priming has occurred in the p,  MT ani- 
mals is  evidenced by the appropriate  surface expression  of 
CD4 + T  cell memory markers. When I*MT mice were in- 
jected with HGG in CFA and then challenged in vitro, the 
kinetics  and  magnitude  of the  T  cell  proliferation  were 
similar  to  those  of normal  controls,  demonstrating  that  B 
cells are not necessary for the CD4 + T  cell proliferative re- 
sponse to recall Ag. SN from these same cultures contained 
cytokines indicative  of CD4 + priming in vivo.  Peripheral 
T  cell tolerance was examined both in terms of the subse- 
quent  T  cell proliferation  to HGG, which was greatly di- 
minished,  and by the absence of cytokine secretion.  There 
was no evidence for selective  tolerance  of either Thl-like 
or Th2-1ike CD4 + cells;  instead,  the loss of cytokine tran- 
scription  and  secretion  encompasses  both  subsets.  To- 
gether, these data indicate that Ag presentation by B cells is 
not  required  to  induce  peripheral  T  cell  tolerance  or  to 
mediate initial CD4 + T  cell priming or proliferation to re- 
call Ag. 
The ability to induce a solid tolerant state in antigen-spe- 
cific CD4 + T  cells from p~MT mice clearly shows that pro- 
fessional  APCs  (e.g.,  dendritic  cells  [DCs]  and  macro- 
phages)  are  sufficient  for  the  induction  of  peripheral 
tolerance. A  single injection of DHGG induced T  cell tol- 
erance  in  the  FtMT mice.  Furthermore,  the level of toler- 
ance achieved in the DMT CD4 + T  cells was similar to that 
of normal  mice  in  terms  of Ag-specific proliferation  and 
loss of cytokine production.  The fact that peripheral  toler- 
ance to exogenous Ag can be induced in p,  MT mice does 
not conflict with work showing that Ag presentation by B 
cells  can induce tolerance in naive T  cells  (10,  11).  How- 
ever,  it  does  disallow  the  hypothesis  that  only B  cell Ag 
presentation  induces tolerance  whereas  all  other APCs are 
immunogenic,  an idea put forth to explain  the phenome- 
non  of low-zone/hi-zone tolerance  (10,  11,  26).  Accord- 
ing to this  theory, at extremely low doses of Ag, the spe- 
cific B  cells  would preferentially pick up Ag through high 
affinity binding to surface Ig. Because resting B  cells do not 
1342 TNF-ot, or generators of these cytokines interferes with the 
induction of tolerance to DHGG  (36, 37). If, however, the 
APC presents Ag in the absence of any costimulatory sig- 
nals,  the result should be tolerance rather than immunity. 
This argues that every APC has the ability to present Ag in 
either a tolerogenic or an immunogenic fashion, depending 
on such factors as the form of the Ag (e.g., deaggregated vs. 
particulate), the route of Ag administration, and  the pres- 
ence of cytokines released by activated APCs. 
This work was  supported by United States  Public Health  Service Grant AI-15761  (W.O. Weigle) and 
CA20408 (L.D. Shultz). This is manuscript number 8974-IMM from the Scripps Research Institute. 
Address correspondence to William O.  Weigle, Department of Immunology, IMM-9, The  Scripps  tke- 
search  Institute,  10666  North Torrey Pines Road,  La JoUa, CA 93037.  D.N.  Ernst's present address  is 
PharMingen, LaJolla, CA 92037. 
Received  for publication  2  October  1995 and in revised form 29 November 1995. 
References 
1. Janeway, C.A., Jr., J. Ron, and M.E. Katz. 1987.  The B cell 
is the initiating antigen-presenting cell in peripheral lymph 
nodes.J. Immunol.  138:1051-1055. 
2.  Ron, Y., andJ. Sprent. 1987.  T cell priming in vivo: a major 
role  for B  cells in  presenting antigen  to  T  cells in  lymph 
nodes.J. Immunol.  138:2848-2856. 
3.  Kurt-Jones,  E.A., D.  Liano, K.A.  HayGlass, B.  Benacerraf, 
M.-S. Sy, and A.K. Abbas. 1988. The role of antigen present- 
ing B cells in T cell priming in vivo: studies of B cell deficient 
mice.J. Immunol.  140:3773-3778. 
4.  Constant,  S.,  D.  Sant'Angelo, T.  Pasqualini, T.  Taylor, D. 
Levin, tk. Flavell, and K. Bottomly. 1995.  Peptide and pro- 
tein antigens require distinct antigen-presenting cell subsets 
for the priming ofCD4 + T cells.J. Immunol.  154:4915-4923. 
5.  Liu, Y., Y. Wu, L. Ramarathinam, Y.  Guo, D. Huszar, M. 
Trounstine,  and M.  Zhao.  1995.  Gene-targeted B-deficient 
mice reveal a critical role for B  cells in the CD4  T  cell re- 
sponse. Int. Immunol. 7:1353-1362. 
6.  Sunshine, G.H., B.L. Jimmo, C. Ianelli, and L. Jarvis. 1991. 
Strong  priming  of T  cells  adoptively transferred  into  scid 
mice.J. Exp. Meal. 174:1653-1656. 
7.  konchese,  F.,  and B.  Housmann.  1993.  B  lymphocytes in 
vivo fail to  prime  naive  T  cells but can stimulate antigen- 
experienced T lymphocytes. J. Exp. Mecl. 164:679--690. 
8.  Epstein,  M.M.,  F.  Di  Rosa,  D. Jankovic,  A.  Sher,  and  P. 
Matzinger. 1995. Successful T cell priming in B cell-deficient 
mice.J. Exp. Med.  182:915-922. 
9.  Chen, J., M. Trounstine, F.W. Alt, C. Kurahara, J.F. Loring, 
and D.  Huszar.  1993.  Imrnunoglobulin gene rearrangement 
in B  deficient mice generated by targeted deletion of the JH 
locus. Int. Immunol.  6:647-653. 
10. Eynon, E.E., and D.C. Parker. 1992.  Small B cells as antigen- 
presenting cells in the induction of tolerance to soluble pro- 
tein antigens.J. Exp. Med.  175:131-138. 
11. Fuchs, E.J.,  and P.  Matzinger.  1992.  B  cells turn off virgin 
but not memory T cells. Science (Wash.  DC). 258:1156-1159. 
12. Gilbert, K.M., and W.O. Weigle. 1992.  B  cell presentation 
ofa tolerogenic signal.  Cell. Immunol.  139:58-71. 
13. Kitamura, D.,J. 1Loes, R.. Kuhn, and K. Rajewski. 1991. A B 
cell-deficient mouse by targeted disruption of the membrane 
exon  of the  immunogloblin p~  chain  gene.  Nature  (Lond.). 
350:423-426. 
1343  Phillips et al. 
14. Chiller, J.M., G.S. Habicht, and W.O. Weigle. 1971. Kinetic 
differences in unresponsiveness of thymus and bone marrow 
cells. Science (Wash.  DC). 171:813-815. 
15. Weigle, W.O.  1980.  Analysis of autoimmunity through ex- 
perimental models ofthyroiditis and allergic encephalomyeli- 
tis. Adv. Immunol.  30:159-273. 
16. Romball, C.G., and W.O. Weigle. 1993.  In vivo induction 
of tolerance in murine CD4 + cell subsets. J. Exp.  Med.  178: 
1637-1644. 
17. Chu,  E.B.,  D.N.  Ernst,  M.V.  Hobbs,  and  W.O.  Weigle. 
1994.  Maturational changes in CD4 +  cell subsets  and lym- 
phokine production in BXSB  mice. J.  Immunol.  152:4129- 
4138. 
18. Doyle, M.V., D.E.  Parks, and W.O. Weigle. 1976.  Specific 
suppression of the immune response by HGG tolerant spleen 
cells. I. Parameters affecting the level of suppression. J. Immu- 
nol. 116:1640-1645. 
19. Chomczynski, P., and N. Sacci. 1987.  Single step method of 
RNA  isolation  by  acid  guanidinium  thiocyanate--phenol- 
chloroform extraction. Anal. Biochem. 162:156-159. 
20. Hobbs,  M.V.,  W.O.  Weigle,  D.J.  Noonan,  B.E.  Torbett, 
R.J.  McEvilly, 1L.J. Koch,  G.J.  Cardenas,  and D.N.  Ernst. 
1993.  Patterns of cytokine gene expression by CD4 + T  cells 
from young and old mice.J. Immunol.  150:3602-3614. 
21. Ernst, D.N.,  W.O. Weigle, D.J.  Noonan,  D.N.  McQuitty, 
and M.V. Hohbs.  1993.  The age-associated increase in IFN- 
"/synthesis by mouse CD8 + T  cells correlates with shifts in 
the frequencies of cell subsets  defined by membrane CD44, 
CD45RB,  3Gll, and MEL-14 expression. J.  Immunol.  151: 
575-587. 
22. Ernst,  D.N.,  M.V.  Hobbs,  B.E.  Torbett,  A.L.  Glasebrook, 
M.A. Rehse, K. Bottomly, K. Hayakawa, 1L.R.  Hardy, and 
W.O. Weigle. 1990.  Differences in the expression profiles of 
CD45RB,  Pgp-1, and 3Gll membrane antigens and in the 
patterns of lymphokine secretion by splenic CD4 +  T  cells 
from young and aged mice.J. Immunol.  145:1295-1302. 
23. Budd, tk.C., J.-C.  Cerottini, C.  Horvath, C.  Bron,  T.  Pe- 
drazzini, R.C. Howe, and HAL. MacDonald. 1987.  Distinc- 
tion of virgin and memory T lymphocytes. Stable acquisition 
of the Pgp-1 glycoprotein concomitant with antigenic stimu- 
lation.J, lmmunol.  138:3120-3129. 
24. Birkeland, M.L., P. Johnson,  l.S. Trowbridge, and E. Pure. 1989.  Changes in CD45 isoform expression accompany anti- 
gen-induced murine T  cell activation. Proc. Natl.  Acad.  Sci. 
USA. 86:6734-6738. 
25. Jung,  T.M., W.M.  Gallatin, I.L. Weissman, and M.O.  Dai- 
ley. 1988.  Down-regulation of homing receptors after T  cell 
activation.J. Immunol.  141:4110-4117. 
26. Matzinger,  P.  1994.  Tolerance,  danger,  and  the  extended 
family. Annu. Rev.  Immunol.  12:991-1045. 
27. Vella, A.T., M.T.  Scherer, L.  Schultz, J.W. Kappler, and P. 
Marrack. 1995.  B  cells are not essential  for peripheral T  cell 
tolerance.  Proc. Natl. Acad.  Sci. USA. 93:951-955. 
28.  Golub, E.S., and W.O. Weigle. 1969.  Studies on the induc- 
tion of immunologic unresponsiveness. III. Antigen form and 
mouse strain variation.J. Immunol.  102:389-396. 
29.  Mitchison, N.A.  1964.  Induction of immunological paralysis 
in two zones of dosage. Proc. R.  Soc. Lond.  B.  Biol.  Sci. 161: 
275-292. 
30. Dresser, D.W.  1965.  Specific inhibition of antibody produc- 
tion. IV. Standardization of antigen-elimination test;  immu- 
nological paralysis  of mice previously immunized.  Immunol- 
ogy. 9:261-273. 
31. Thorbecke, G.J., and B. Benacerraf. 1967.  Tolerance in adult 
rabbits by repeated non-immunogenic doses of bovine serum 
albumin. Immunology.  13:141-145. 
32. Miller, J.F., G. Horahan, J.  Allison, P.S.  Bhathal,  and K.O. 
Cox.  1989.  T-cell tolerance in  transgenic  mice  expressing 
major histocompatibility class I molecules in defined tissues. 
Immunol.  Rev.  107:109-123. 
33.  Schonrich,  G.,  F. Momburg,  M.  Malissen, A.-M. Schmitt- 
Verhulst,  B.  Malissen,  G.J.  Harnmerling,  and  B.  Arnold. 
1992.  Distinct mechanisms of extrathymic T  cell tolerance 
due to differential expression of self antigen. Int.  Immunol.  4: 
581-590. 
34. Ferber, I., G. Schonrich, J. Schenkel, A.L. Mellor, G.J. Ham- 
merling, and B. Arnold. 1994. Levels of peripheral T cell tol- 
erance induced by different doses oftolerogen. Science (Wash. 
DC). 263:674-676. 
35.  Levich, J.D.,  A.P.  Signorella,  G.  Wittenberg,  and  W.O. 
Weigle. 1987.  Macrophage handling of a tolerogen and the 
role of IL 1 in tolerance induction in a helper T cell clone in 
vitro.J. Immunol.  138:3675-3679. 
36.  Weigle, W.O.,  W.V.  Scheuer,  M.V.  Hobbs, E.L.  Morgan, 
and D.E. Parks.  1987.  Modulation of the induction and cir- 
cumvention of immunological tolerance to human ~/-globu- 
lin by interleukin l.J.  Immunol.  138:2069-2074. 
37.  Gahring, L.C., and W.O. Weigle. 1990.  The regulatory ef- 
fects of cytokines on the induction of a peripheral immuno- 
logic tolerance in mice.J, Immunol.  145:1318-1323. 
1344  CD4 + T Cell Activation and Tolerance Induction in B Cell Knockout Mice 